ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS
In one aspect, bispecific proteins having the ability to specifically bind to both subdomain II of human HER2 and subdomain IV of human HER2 are provided. In another aspect, methods of treating a cancer or treating brain metastasis of a cancer using a bispecific protein that specifically binds to su...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
22.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In one aspect, bispecific proteins having the ability to specifically bind to both subdomain II of human HER2 and subdomain IV of human HER2 are provided. In another aspect, methods of treating a cancer or treating brain metastasis of a cancer using a bispecific protein that specifically binds to subdomain II and subdomain IV of human HER2 are provided. |
---|---|
Bibliography: | Application Number: US202217819182 |